1-2 of 2
Martin Hofmann
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

The Immune Checkpoint Modulator OX40 and Its Ligand OX40L in NK-Cell Immunosurveillance and Acute Myeloid Leukemia

Tina Nuebling, Carla Emilia Schumacher, Martin Hofmann, Ilona Hagelstein, Benjamin Joachim Schmiedel, Stefanie Maurer, Birgit Federmann, Kathrin Rothfelder, Malte Roerden, Daniela Dörfel, Pascal Schneider, Gundram Jung, Helmut Rainer Salih
Journal: Cancer Immunology Research
Cancer Immunol Res (2018) 6 (2): 209–221.
https://doi.org/10.1158/2326-6066.CIR-17-0212
Published: 31 January 2018
View article titled, The Immune Checkpoint Modulator OX40 and Its Ligand OX40L in NK-Cell Immunosurveillance and Acute Myeloid Leukemia
Open the PDF for The Immune Checkpoint Modulator OX40 and Its Ligand OX40L in NK-Cell Immunosurveillance and Acute Myeloid Leukemia in another window
Includes: Supplementary data
Journal Articles

Abstract B144: Reduction of minimal residual disease in pediatric B-precursor acute lymphoblastic leukemia by an Fc-optimized CD19 antibody

Ursula Joerdis Eva Seidel, Ludger Grosse-Hovest, Patrick Schlegel, Martin Hofmann, Friedhelm R. Schuster, Roland Meisel, Kai-Erik Witte, Steffen Aulwurm, Elwira Pyz, Hans-Georg Rammensee, Gundram Jung, Rupert Handgretinger, Peter Lang
Journal: Cancer Immunology Research
Cancer Immunol Res (2016) 4 (1_Supplement): B144.
https://doi.org/10.1158/2326-6074.CRICIMTEATIAACR15-B144
Published: 03 January 2016
View article titled, Abstract B144: Reduction of minimal residual disease in pediatric B-precursor acute lymphoblastic leukemia by an Fc-optimized CD19 antibody